Cross Cancer Institute /ID# 269392

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer — Running, not enrolling